Referring physicians underestimate the extent of abnormalities in final reports from myocardial perfusion imaging by Elin Trägårdh et al.
Trägårdh et al. EJNMMI Research 2012, 2:27
http://www.ejnmmires.com/content/2/1/27ORIGINAL RESEARCH Open AccessReferring physicians underestimate the extent of
abnormalities in final reports from myocardial
perfusion imaging
Elin Trägårdh1*, Peter Höglund2, Mattias Ohlsson3, Mattias Wieloch4 and Lars Edenbrandt1Abstract
Background: It is important that referring physicians and other treating clinicians properly understand the final
reports from diagnostic tests. The aim of the study was to investigate whether referring physicians interpret a final
report for a myocardial perfusion scintigraphy (MPS) test in the same way that the reading nuclear medicine
physician intended.
Methods: After viewing final reports containing only typical clinical verbiage and images, physicians in nuclear
medicine and referring physicians (physicians in cardiology, internal medicine, and general practitioners)
independently classified 60 MPS tests for the presence versus absence of ischemia/infarction according to objective
grades of 1–5 (1 = No ischemia/infarction, 2 = Probably no ischemia/infarction 3 = Equivocal, 4 = Probable ischemia/
infarction, and 5 = Certain ischemia/infarction). When ischemia and/or infarction were thought to be present in the
left ventricle, all physicians were also asked to mark the involved segments based on the 17-segment model.
Results: There was good diagnostic agreement between physicians in nuclear medicine and referring physicians
when assessing the general presence versus absence of both ischemia and infarction (median squared kappa
coefficient of 0.92 for both). However, when using the 17-segment model, compared to the physicians in nuclear
medicine, 12 of 23 referring physicians underestimated the extent of ischemic area while 6 underestimated and 1
overestimated the extent of infarcted area.
Conclusions: Whereas referring physicians gain a good understanding of the general presence versus absence of
ischemia and infarction from MPS test reports, they often underestimate the extent of any ischemic or infarcted
areas. This may have adverse clinical consequences and thus the language in final reports from MPS tests might be
further improved and standardized.
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Whenever diagnostic tests are performed, it is important
that referring physicians fully understand the final re-
port, written for example by other physicians who are
most often radiologists or pathologists. If the message in
the final report is not precisely understood, the patient
might receive inadequate, inappropriate or potentially
even harmful treatment. Numerous studies have investi-
gated the sources for potential clinical errors in many* Correspondence: elin.tragardh@med.lu.se
1Clinical Physiology and Nuclear Medicine Unit, Skåne University Hospital,
Lund University, Entrance 44, Malmö, 205 05, Sweden
Full list of author information is available at the end of the article
© 2012 Tragardh et al.; licensee Springer. This i
Attribution License (http://creativecommons.or
in any medium, provided the original work is pdifferent diagnostic methods, including technical aspects
and inter- and intra observer variability. However, to our
knowledge, none have investigated whether the referring
physician understands the message sent in the final re-
port by the diagnostic physician.
Stress myocardial perfusion scintigraphy (MPS) is
widely regarded as a clinically useful non-invasive im-
aging modality for diagnosing patients with suspected
coronary artery disease [1-3]. When a physician refers a
patient to a MPS, the physician wants to know whether
ischemia and/or infarction are present, as well as the ex-
tent and severity of any perfusion defects. In order to
optimally manage the patient, the referring physicians an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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nuclear medicine specialist. The American Society of
Nuclear Cardiology, European Association of Nuclear
Medicine and European Society of Cardiology have pub-
lished guidelines, articles and editorials that address the
importance of reporting in an understandable manner
[4-10].
Current guidelines recommend that MPS reports
should be concise and couched in language that is easily
understandable to referring physicians [10]. As a stand-
ard, the reports should consist of information about pa-
tient details, indication(s) for study, stress technique,
tracer and imaging protocol, findings, and conclusion. In
the conclusion section, information about left ventricular
perfusion (presence/absence of inducible ischemia and/
or infarction), left ventricular function (global and re-
gional function, possible stress-induced abnormalities),
inconclusive study (may occasionally be the correct con-
clusion) and correlation with and deviations from clin-
ical information and other data if available, should be
included.
The principal aim of the present study was to investi-
gate whether referring physicians (cardiologists, inter-
nists and general practitioners) interpret the final
reports from MPS tests in the same way as intended by
the nuclear medicine physicians who generate the
written final reports. A secondary aim was to examine
the details of any differences in objective classifications
that occur between referring and nuclear medicine
physicians.
Methods
Initially, MPS tests performed at the Department of Nu-
clear Medicine, Skåne University Hospital, Malmö,
Sweden during January-July 2011 were considered for
inclusion in the study. Tests performed by six of the
physicians at the department were included (one resi-
dent with 1.5 years of experience in MPS, whose final
reports were approved by a senior physician, and 5 spe-
cialists in nuclear medicine and/or clinical physiology).
The MPS tests were selected by one study investigator
(ET) in order to include 10 results from each of the six
nuclear medicine physicians, of which only 3 tests from
each physician had completely normal results. For
results to be considered “completely normal”, both “no
infarction” and “no inducible ischemia” had to be clearly
indicated in the conclusion section of the final report, i.
e. the study investigator who selected the cases was to
be almost sure that the report should be assessed as cer-
tainly “no ischemia” and “no infarction”. Only 3 com-
pletely normal results from each physician were chosen
in order to obtain a larger variety of reports with abnor-
malities because in our hospital’s laboratory, more than
50% of MPS test results are considered normal. Each ofthe physicians in nuclear medicine were asked to fill in a
questionnaire (Figure 1) based on the final reports for
their own 10 included patients. They then assessed the
tests based on the presence versus absence of ischemia/
infarction in grades of 1–5 (1 =No ischemia/infarction,
2 = Probably no ischemia/infarction 3 = Equivocal,
4 = Probable ischemia/infarction, and 5 =Certain ische-
mia/infarction). When ischemia and/or infarction were
thought to be present in the left ventricle, the same phy-
sicians were then also asked to mark the involved seg-
ments based on the 17-segment model. The only other
information provided beyond the original written final
report and images for the MPS was patient age and
gender.
Thirty physicians from specialties who often refer
patients for MPS tests were presented with the 60 final
reports, and were asked to fill in the same questionnaire.
Of these, 10 were cardiologists, 10 were internists and
10 were general practitioners. Twenty-three physicians
chose to participate in the study: 8 cardiologists, 7 inter-
nists, and 8 general practitioners. Twelve of these physi-
cians were already specialists and 11 were residents.
MPS
The MPS tests were performed per clinical routine in
our department, using a 2-day gated stress/non-gated
rest Tc-99 m-tetrofosmin protocol, starting with an in-
jection of 600 MBq Tc-99 m-tetrofosmin at stress.
Patients were stressed either by maximal exercise (ergo-
metry) or pharmacologically by adenosine. The exercise
test was continued for at least 1 min after the injection
of the tracer and the adenosine infusion for at least
2 min after the injection of the tracer. Normal findings
at stress were not followed by a rest study. Stress studies
that were not completely normal were followed by a rest
study with injection of 600 MBq Tc-99 m-tetrofosmin.
Stress and rest acquisition began about 60 min after
the end of the injection of Tc-99 m-tetrofosmin. Images
were obtained according to established clinical proto-
cols, using single photon emission computed tomog-
raphy over 180° elliptical, autocontour rotations from
the 45° right anterior oblique position, with a dual-head
gamma camera, e.cam (Siemens AG Medical Solutions,
Erlangen, Germany). Patients were imaged in the supine
position. A low energy high-resolution collimator and a
zoom factor of 1.0 were used. We obtained 64 (32 views
per camera) projections in a 128 x 128 matrix, with an
acquisition time of 20 s per projection. Stress images
were gated to the electrocardiogram using 8 frames per
cardiac cycle. No automatic motion-correction program
was applied; instead the acquisition was repeated if mo-
tion was detected. Tomographic reconstruction and cal-
culation of short and long axis slice images were
performed using e.soft (Siemens AG Medical Solutions,
Is ischemia present?   If probable/certain ischemia – where? (mark the involved segments) 
1 No ischemia  
2 Probably no ischemia  
3 Equivocal  
4 Probable ischemia  
5 Certain ischemia 
Is infarction present?   If probable/certain infarction – where? (mark the involved segments)  
1 No infarction 
2 Probably no infarction 
3 Equivocal 
4 Probable infarction 
5 Certain infarction 
Left ventricular segmentation: 
1. Basal anterior 2. Basal anteroseptal 3. Basal inferoseptal
4. Basal inferior 5. Basal inferolateral 6. Basal anterolateral
7. Med anterior 8. Mid anteroseptal 9. Mid inferoseptal
10. Mid inferior 11. Mid inferolateral 12. Mid anterolateral
13. Apical anterior 14. Apical septal 15. Apical inferior 
16. Apical lateral 17. Apex
Figure 1 The questionnaire filled in by both the physicians at the nuclear medicine department and referring physicians.
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were reconstructed with filtered back-projection. A 2D
Butterworth pre-reconstruction filter was used with cut-
off frequency of 0.45, order 5. Attenuation corrected
images were reconstructed with an iterative algorithm, 6
iterations where a ramp filter was applied on the error
projection prior to backprojection. A Butterworth filter
with a cut-off frequency of 0.40, order 5, was applied for
regularization. Attenuation maps were generated from
simultaneous transmission measurement using a Gd-153
multiple-line source (Siemens AG Medical Solutions,
Erlangen, Germany).
Reports
The reports were written according to local clinical rou-
tine in EXINI heartTM (EXINI Diagnostics AB, Lund
Sweden), and typically consisted of three headings: Stress
technique, Findings, and Conclusion. Copies of the
images, chosen by the interpreting physician, accompan-
ied the report: three short axis slices (apical, mid, basal),one vertical long axis and one horizontal long axis for
stress images. For rest images, the corresponding slices
were shown, aligned to the stress images. Attenuation
corrected images were used by default, but if the inter-
preting physician elected to include non-attenuation cor-
rected images instead, this was possible. A typical
normal report is shown in Figure 2.
Statistical analysis
For analysis of agreement between the physicians in nu-
clear medicine and the referring physicians, the percent-
age agreement (PA) and the squared kappa coefficient
(which measures agreement beyond that expected by
chance) were calculated. Squared kappa was used be-
cause disagreement by an increasing number of grades
on the five-grade scale potentially has increasingly more
serious clinical consequences.
Disagreement between the physician in nuclear medi-
cine and the referring physician can be systematic and/or
random. To quantify the disagreement between paired-
Stress protocol
Pharmacologic stress testing was performed with adenosine.
ECG: Normal ECG. 
Findings
Homogeneous tracer distribution throughout the myocardium, both at stress and 
at rest. 
The ejection fraction of the left ventricle was > 70% at rest, and the end diastolic volume was 
125 ml. 
Conclusion
No inducible myocardial ischemia. No defects indicative of myocardial infarction. Normal 
systolic function of the left ventricle.
Figure 2 Example of a routine MPS test result reported as normal.
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et al [11, 12] was used. Two types of systematic variation
are possible: overestimation or underestimation of the
classifications and concentration of the classification. Sys-
tematic overestimation or underestimation occurs when
an observer regularly classifies cases as being more or less
abnormal than another observer does. This is reflected by
the variable relative position (RP) and possible values
range from −1 to 1. A value of 0 indicates that no system-
atic disagreement is present. A positive RP value reflects
systematic overestimation of the classifications, while a
negative RP value reflects systematic underestimation.
Systematic concentration occurs when an observer
more often uses the middle part of the five-grade scale
(grades 2–4) than another observer who uses “no ische-
mia/infarction” or “certain ischemia/infarction” (grades 1
and 5) more often. This is reflected by the variable rela-
tive concentration (RC). The possible values for RC also
range from −1 to 1, where a value of 0 indicates that no
systematic disagreement is present. The RC value is
positive if systematic concentration to the central part of
the five-grade scale is present and negative when system-
atic concentration to the extremity grades is present.The pattern of random differences was quantified
using the variable of relative rank variance (RV). Ran-
dom errors could be caused by guessing or loss of con-
centration. The possible values for RV range from 0 to
1, with 0 indicating no random contribution.
For the analysis of differences in the interpretation of
the 17-segment model for presence/absence of ischemia/
infarction, the Durkalski method was used [13]. This is a
method for the analysis of clustered matched-pair data
that adjusts for multiple units within a cluster, yet avoids
correlation assumptions among and within clusters and
also avoids distributional assumptions (modification of
the McNemar test). The level of statistical significance
was set at p< 0.05.
Results
Assessment of ischemia and infarction made by the
nuclear medicine physician
In relation to ischemia, the nuclear medicine physicians
classified the result as “no ischemia” in 32 cases, as
“probably no ischemia” in 5 cases, as “equivocal” in 0
cases, as “probable ischemia” in 14 cases, and as “certain
ischemia” in 9 cases. In relation to infarction, the nuclear
Table 1 Analysis of the assessment of ischemia
Physician Specialty Title K_sq PA RC RP RV
1 GP S 0.83 35 0.736 0.251 0.000
2 GP R 0.93 65 −0.007 0.139 0.007
3 GP S 0.89 65 −0.192 −0.003 0.016
4 GP R 0.87 55 0.295 0.030 0.033
5 GP R 0.95 72 −0.210 0.054 0.005
6 GP R 0.89 65 0.120 0.090 0.034
7 GP S 0.91 72 0.085 −0.078 0.015
8 GP S 0.96 75 −0.283 0.013 0.000
9 IM R 0.93 73 −0.219 0.038 0.002
10 IM R 0.96 73 −0.188 0.031 0.004
11 IM R 0.95 73 −0.149 0.018 0.006
12 IM R 0.92 72 −0.027 0.113 0.006
13 IM S 0.92 82 −0.111 −0.067 0.007
14 IM R 0.87 45 0.374 0.142 0.031
15 IM S 0.93 65 0.128 0.039 0.016
16 C S 0.94 72 −0.165 0.040 0.002
17 C S 0.89 55 0.356 0.108 0.010
18 C R 0.73 63 0.147 −0.063 0.027
19 C S 0.95 75 −0.067 0.023 0.005
20 C S 0.96 80 −0.105 0.004 0.001
21 C S 0.97 80 −0.149 0.018 0.002
22 C R 0.90 65 0.103 −0.036 0.010
23 C S 0.90 70 −0.189 −0.048 0.006
Median 0.92 72 −0.067 0.030 0.006
GP – general practitioner, IM – internal medicine, C – cardiologist, S –
specialist, R – resident, K_sq – squared kappa, PA – percentage agreement, RC
– relative concentration, RP – relative proportion, RV – relative rank variance.
Table 2 Classifications for ischemia for three individual
referring physicians; general practitioner #1 (A), #8 (B)
and cardiologist #4 (C). 1 = no ischemia, 2 = probably no
ischemia, 3 = equivocal, 4 =probable ischemia, 5 = certain
ischemia
A.
Physicians in nuclear medicine
1 2 3 4 5 Total
GP#1 5 0
4 14 9 23
3 0
2 30 5 35
1 2 2
Total 32 5 0 14 9 60
GP – general practitioner
B.
Physicians in nuclear medicine
1 2 3 4 5 Total




5 32 5 37
Total 32 5 0 14 9 60
GP – general practitioner
C.
Physicians in nuclear medicine
1 2 3 4 5 Total
C#4 1 6 7 13
2 7 2 9
3 1 1 2
4 2 2 4
5 29 3 32
Total 32 5 0 14 9 60
C – cardiologist
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tion” in 31 cases, as “probably no infarction” in 3 cases,
as “equivocal” in 3 cases, as “probable infarction” in 7
cases and as “certain infarction” 16 cases. In total, 18 of
the 60 tests were considered completely normal by the
nuclear medicine physicians.GP, general practitioner; IM, internal medicine; C, cardiologist; S, specialist; R,
resident; K_sq, squared kappa; PA, percentage agreement; RC, relative
concentration; RP, relative position; RV, relative rank variance.Analysis of classification of ischemia
Table 1 shows squared kappa, PA, RC, RP and RV for the
classifications of the 23 referring physicians when refer-
enced to those of the nuclear medicine physicians. The
median squared kappa coefficient for all referring physi-
cians was 0.92 (0.90 for general practitioners, 0.93 for
internists and 0.92 for cardiologists). The median PA for
all referring physicians was 72% (65% for general practi-
tioners, 73% for internists and 71% for cardiologists).
The results from one physician (general practitioner #1)
whose classifications for ischemia were systematically shifted
in concentration towards grades 2–4 (central grade categor-
ies) are shown in Table 2A. The RC for this physician washighly positive (0.74). The results for another physician (gen-
eral practitioner #8) whose classifications were systematically
shifted in concentration towards grades 1 and 5 are shown
in Table 2A. The RC for this physician was negative (−0.28).
The results from a physician (cardiologist #4) who had the
median value of RC (−0.067) are shown in Table 2C.Analysis of classification of infarction
Squared kappa values, PA, RC, RP and RV for all physi-
cians are shown in Table 3. For the 23 referring physicians,
Table 3 Analysis of the assessment of infarction
Physician Specialty Title K_sq PA RC RP RV
1 GP S 0.80 18 0.740 0.173 0.024
2 GP R 0.88 73 0.029 −0.025 0.007
3 GP S 0.89 80 −0.057 −0.032 0.010
4 GP R 0.84 43 0.457 0.031 0.022
5 GP R 0.96 82 −0.055 −0.016 0.020
6 GP R 0.88 72 0.180 0.098 0.001
7 GP S 0.89 60 0.317 −0.058 0.001
8 GP S 0.96 75 −0.079 −0.023 0.005
9 IM R 0.93 75 −0.129 0.083 0.007
10 IM R 0.87 72 −0.158 0.066 0.014
11 IM R 0.90 75 0.092 0.078 0.004
12 IM R 0.92 70 0.171 0.079 0.002
13 IM S 0.92 78 −0.098 −0.088 0.001
14 IM R 0.92 58 0.288 0.063 0.006
15 IM S 0.95 70 0.151 0.030 0.004
16 C S 0.95 80 0.070 0.026 0.004
17 C S 0.92 62 0.310 0.049 0.000
18 C R 0.74 70 0.055 −0.035 0.045
19 C S 0.92 67 −0.049 0.058 0.009
20 C S 0.96 83 −0.080 −0.021 0.002
21 C S 0.97 80 −0.107 0.059 0.000
22 C R 0.85 63 0.075 −0.064 0.019
23 C S 0.95 77 −0.138 0.001 0.002
Median 0.92 72 0.055 0.030 0.005
GP – general practitioner, IM – internal medicine, C – cardiologist, S – specialist,
R – resident, K_sq – squared kappa, PA – percentage agreement, RC – relative
concentration, RP – relative position, RV – relative rank variance.
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general practitioners, 0.92 for internists and 0.93 for cardi-
ologists). Median PA was 72% (73% for general practi-
tioners, 72% for internists and 73% for cardiologists).
Analysis of the 17-segment model for ischemia
Considering all 60 patients and thus the 17*60= 1020 total
segments evaluated, the physicians in nuclear medicine
marked a total of 65 segments as ischemic and 955 as
non-ischemic. A statistically significant underestimation
of the ischemic area (compared to the estimates from the
physicians in nuclear medicine) was noted for 12 of the 23
referring physicians, a statistically significant overesti-
mation for none, and no statistically significant differences
for the remaining 11 referring physicians.
Analysis of the 17-segment model for infarction
The physicians in nuclear medicine marked a total of 75
segments as infarcted and 945 as non-infarcted. A statis-
tically significant underestimation of the infarcted area(compared to the estimates from the physicians in nu-
clear medicine) was noted for 6 of the 23 referring phy-
sicians, a statistically significant overestimation for one,
and no statistically significant differences for the other
16 referring physicians.
Equivocal cases
Whereas in no report in this study was ischemia classified
as “equivocal” by the physicians in nuclear medicine, the
infarction result was ultimately classified as “equivocal” in
3 cases (example shown in Figure 3). Of the referring phy-
sicians, only 4, 1 and 0 correctly identified these 3 respect-
ive cases as “equivocal”. The remaining physicians varied
in their answers from “no infarction” to “certain infarc-
tion”. In all 3 cases, the physician in nuclear medicine did
not write anything about fixed defects/infarcts in the con-
clusion section, and only used verbiage such as “inhomo-
geneous tracer distribution in the . . . wall at rest” or
“mildly reduced tracer distribution. . .” etc., in the descrip-
tion section of the scintigraphy findings.
Discussion
The principal aim of this study was to investigate
whether referring physicians understand the final MPS
report as intended by the physician responsible for the
image interpretation at the nuclear medicine depart-
ment. Generally, there was a good agreement between
the physicians at the nuclear department interpreting
the examination and the referring physicians with a high
squared kappa coefficient and a reasonably high PA. In a
few cases, the PA was less than 50% for the classifica-
tions of both ischemia and infarction. The squared
kappa coefficients were high despite these low PAs since
the classifications made by the referring physicians were
close to the ones made by the physician at the nuclear
department on the five-grade scale. The explanation for
some of the low PAs was systematic differences in RC,
more apparent when evaluating ischemia than infarction.
For example, the general practitioner described in
Table 2A had a low PA and a high RC, but his classifica-
tions did not deviate by more than 1 grade on the five-
grade scale from the classifications made by the physi-
cians in nuclear medicine. High absolute RV values were
explained by high absolute RC values, since many of the
patients did not have ischemia or infarction (n = 32 had
no ischemia; n = 31 had no infarction). Thus the differ-
ences between physicians were due to systematic differ-
ences in RC and not by random differences or
differences in RP, and there was no under- nor over clas-
sification with respect to the main diagnosis but only
with respect to the extent of ischemic/infarcted area.
Systematic differences in RC values could possibly be
explained by the different practice styles of the referring
physicians, i.e., the extent to which a referring physician
Stress protocol
Pharmacologic stress testing was performed with adenosine.
ECG: Alternating sinus rhythm and ventricular pacing during rest and adenosine infusion.
Findings
Mildly reduced tracer uptake in a small area of the left ventricle in the apical 
inferior/inferolateral wall. During adenosine further reduced tracer uptake in a small area of 
the mid anterior/anteroseptal wall. 
Conclusion
Mild inducible myocardial ischemia in a small area of the mid anterior/anteroseptal wall. 
Figure 3 Example of an MPS test result reported as “equivocal” with regard to infarction.
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Table 2A and Table 2B).
For the classification of infarction, it was clear that
when the physician in nuclear medicine was uncertain
(equivocal) and did not write anything about the pres-
ence or absence of infarction in the conclusion section
of the report, the referring physicians did not under-
stand the message. In these cases, there was a large dif-
ference in the interpretations made by the referring
physicians, and they used the whole range from “no in-
farction” to “certain infarction” for their interpretations.
Thus, it is advisable for the physician at the nuclear
medicine department to clearly state the presence versus
absence of infarction, or its uncertainty, in the conclu-
sion section of the report.
Different departments of nuclear medicine as well as
individual physicians have their own way of writing MPS
reports. Traditions in vocabulary could easily be under-
stood within the local hospital, but could be a challenge
when exchange of patient data across multiple users or
institutions is necessary. In Malmö, where the present
study was performed, the EXINI heartTM software pack-
age is used. The program not only shows the images,
but also interprets the study by using computer assisted
diagnosis and writes a preliminary report based on the
computerized interpretation. The physician responsiblefor the interpretation changes the final report according
to his/her interpretation. If the interpretation made by
the software is considered correct (most often this
occurs in patients with normal results), there is no need
for the physician to change the phrasing in the final re-
port. Thus, the reports written in Malmö, at least for
normal studies, are already fairly standardized. Hospitals
not using templates or structured reports might have a
larger variety in their phrasing, thus making it even
more difficult for referring physicians to understand the
message.
Overall, there was a tendency to underestimate the area
of ischemia and infarction by the referring physicians. This
is potentially troublesome because treatment regimens
may differ when ischemia involves only a small versus
large area of the heart (e.g., medical treatment is generally
preferred if less than 10% of the heart is ischemic whereas
percutaneous coronary intervention may be preferred if
more than 10% is ischemic) [14]. The physicians at the nu-
clear medicine department in Malmö use the 17-segment
model for describing the locations of ischemic and
infarcted areas (using words such as apical, mid-ventricu-
lar, basal, anterior, anteroseptal, septal, etc.) instead of giv-
ing the total percentage of ischemic/infarcted areas.
In general we would propose the use of concise, clear-
cut conclusions (presence or absence of ischemia and
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as number of involved segments or as a percentage of the
left ventricle.
Study limitations
Our study has several potential limitations. For example
it is possible that inclusion of images in the final report
affected our results, although this is standard procedure
at our laboratory and encouraged by current guidelines
[10]. Some referring physicians might have classified the
report based on the images rather than the phrases used
by the physician in nuclear medicine.
None of the 60 cases in the study were classified as
“equivocal” with regard to ischemia by the physicians in
nuclear medicine. Since inducible ischemia is the most
important diagnosis in MPS, it would have been interest-
ing and important to know how an “equivocal” ischemic
finding would have been interpreted by the referring
physicians.
Another limitation is that we did not ask the study
participants to specify the vessel or vessels affected,
something that might also have been of interest.
We used a limited number of referring physicians in
the study, and used only reports written by physicians in
nuclear medicine at the same single hospital. It is pos-
sible that the results would have been different had we
included more referring physicians, and reports from
several different hospitals.
There is also a possibility that the referring physicians
who chose to participate in the study were more inter-
ested in MPS than the 7 physicians who declined.
Conclusions
Whereas referring physicians demonstrate a good under-
standing from MPS reports of the general presence versus
absence of ischemia or infarction in the referred patient,
they often underestimate the extent of any ischemic or
infarcted area. This may have adverse clinical conse-
quences and thus the language in final reports from MPS
tests might be further improved and standardized.
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